ArticleClinical drug investigation2023

A Cross-Sectional Study of Tampering in Xtampza ER, an Abuse-Deterrent Formulation of an Extended-Release Opioid, in a Treatment Center Population.

Jennifer Jewell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.